Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

IBD

Multi-omics in IBD biomarker discovery: the missing links

Multi-omics technologies in gut microbiome research provide a global view of changes in genetic, metabolic and biochemical processes. This approach has now been applied to the gut microbiota in the context of IBD, providing first steps towards a functional understanding of host–microbe interactions during disease pathogenesis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Conceptual model for multi-omics integration towards mechanistic biomarker discovery.

References

  1. Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390, 2769–2778 (2017).

    Article  Google Scholar 

  2. Renz, H. et al. Gene-environment interactions in chronic inflammatory disease. Nat. Immunol. 12, 273 (2011).

    Article  CAS  Google Scholar 

  3. Pascal, V. et al. A microbial signature for Crohn’s disease. Gut 66, 813–822 (2017).

    Article  CAS  Google Scholar 

  4. Yilmaz, B. et al. Microbial network disturbances in relapsing refractory Crohn’s disease. Nat. Med. 25, 323–336 (2019).

    Article  CAS  Google Scholar 

  5. Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655–662 (2019).

    Article  CAS  Google Scholar 

  6. Rath, E., Moschetta, A. & Haller, D. Mitochondrial function — gatekeeper of intestinal epithelial cell homeostasis. Nat. Rev. Gastroenterol. Hepatol. 15, 497–516 (2018).

    Article  CAS  Google Scholar 

  7. Linge, H. M. et al. The Human CXC Chemokine Granulocyte Chemotactic Protein 2 (GCP-2)/ CXCL6 Possesses Membrane-Disrupting Properties and Is Antibacterial. Antimicrob. Agents Chemother. 52, 2599–2607 (2008).

    Article  CAS  Google Scholar 

  8. Jain, U., Otley, A. R., Van Limbergen, J. & Stadnyk, A. W. The Complement System in Inflammatory Bowel Disease. Inflamm. Bowel Dis. 20, 1628–1637 (2014).

    Article  Google Scholar 

  9. Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623 (2018).

    Article  CAS  Google Scholar 

  10. Nagao-Kitamoto, H. et al. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice. Cell. Mol. Gastroenterol. Hepatol. 2, 468–481 (2016).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dirk Haller.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Metwaly, A., Haller, D. Multi-omics in IBD biomarker discovery: the missing links. Nat Rev Gastroenterol Hepatol 16, 587–588 (2019). https://doi.org/10.1038/s41575-019-0188-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-019-0188-9

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing